Your browser doesn't support javascript.
loading
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study.
Desilets, Antoine; Blanc-Durand, Félix; Lau, Sally; Hakozaki, Taiki; Kitadai, Rui; Malo, Julie; Belkaid, Wiam; Richard, Corentin; Messaoudene, Meriem; Cvetkovic, Lena; Kazandjian, Suzanne; Tehfe, Mustapha; Florescu, Marie; Jao, Kevin; Daaboul, Nathalie; Owen, Scott; Shieh, Benjamin; Agulnik, Jason; Cohen, Victor; Charbonneau, Chloé; Marcoux, Nicolas; Blais, Normand; Leighl, Natasha B; Bradbury, Penelope A; Liu, Geoffrey; Shepherd, Frances A; Bahig, Houda; Routy, Bertrand; Sacher, Adrian; Elkrief, Arielle.
Afiliação
  • Desilets A; Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM), 900, Rue Saint-Denis, Pavillon R, H2X 0A9, Montreal, Quebec, Canada; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Montréal (CHUM), 1051, Rue Sanguinet, H2X 3E4, Montreal, Quebec, Canada. E
  • Blanc-Durand F; Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM), 900, Rue Saint-Denis, Pavillon R, H2X 0A9, Montreal, Quebec, Canada; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Montréal (CHUM), 1051, Rue Sanguinet, H2X 3E4, Montreal, Quebec, Canada. E
  • Lau S; Princess Margaret Cancer Centre, University Health Network (UNH), 610 University Ave, M5G 2C1, Toronto, Ontario, Canada. Electronic address: sally.lau@uhn.ca.
  • Hakozaki T; Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, 113-8677, Bunkyo City, Tokyo, Japan. Electronic address: t-hakozaki@cick.jp.
  • Kitadai R; Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, 113-8677, Bunkyo City, Tokyo, Japan. Electronic address: rkitadai@cick.jp.
  • Malo J; Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM), 900, Rue Saint-Denis, Pavillon R, H2X 0A9, Montreal, Quebec, Canada. Electronic address: julie.malo.chum@ssss.gouv.qc.ca.
  • Belkaid W; Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM), 900, Rue Saint-Denis, Pavillon R, H2X 0A9, Montreal, Quebec, Canada. Electronic address: wiam.belkaid.chum@ssss.gouv.qc.ca.
  • Richard C; Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM), 900, Rue Saint-Denis, Pavillon R, H2X 0A9, Montreal, Quebec, Canada. Electronic address: corentin.richard@umontreal.ca.
  • Messaoudene M; Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM), 900, Rue Saint-Denis, Pavillon R, H2X 0A9, Montreal, Quebec, Canada. Electronic address: meriem.messaoudene@umontreal.ca.
  • Cvetkovic L; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Montréal (CHUM), 1051, Rue Sanguinet, H2X 3E4, Montreal, Quebec, Canada. Electronic address: lena.cvetkovic@umontreal.ca.
  • Kazandjian S; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Montréal (CHUM), 1051, Rue Sanguinet, H2X 3E4, Montreal, Quebec, Canada. Electronic address: suzanne.kazandjian@mail.mcgill.ca.
  • Tehfe M; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Montréal (CHUM), 1051, Rue Sanguinet, H2X 3E4, Montreal, Quebec, Canada. Electronic address: mustapha.tehfe.chum@ssss.gouv.qc.ca.
  • Florescu M; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Montréal (CHUM), 1051, Rue Sanguinet, H2X 3E4, Montreal, Quebec, Canada. Electronic address: marie.florescu.chum@ssss.gouv.qc.ca.
  • Jao K; Department of Hematology and Oncology, Hôpital Du Sacré Coeur de Montréal, 5400, Boulevard Gouin Ouest, H4J 1C5, Montreal, Quebec, Canada. Electronic address: kevin.jao@umontreal.ca.
  • Daaboul N; Integrated Cancer Center, Charles-Le-Moyne Hospital, 3120, Boulevard Taschereau, J4V 2H1, Greenfield Park, Quebec, Canada. Electronic address: nathalie.daaboul@usherbrooke.ca.
  • Owen S; Cedars Cancer Center, McGill University Healthcare Center (MUHC), 1001, Boulevard Décarie, H4A 3J1, Montreal, Quebec, Canada. Electronic address: scott.owen@mcgill.ca.
  • Shieh B; Cedars Cancer Center, McGill University Healthcare Center (MUHC), 1001, Boulevard Décarie, H4A 3J1, Montreal, Quebec, Canada. Electronic address: benjamin.shieh@mcgill.ca.
  • Agulnik J; Segal Cancer Center, Jewish General Hospital, 3755, Chemin de La Côte-Sainte-Catherine, H3T 1E2, Montreal, Quebec, Canada. Electronic address: jagulnik@jgh.mcgill.ca.
  • Cohen V; Segal Cancer Center, Jewish General Hospital, 3755, Chemin de La Côte-Sainte-Catherine, H3T 1E2, Montreal, Quebec, Canada. Electronic address: vcohen@jgh.mcgill.ca.
  • Charbonneau C; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Québec (CHUQ), 11, Côte Du Palais, G1R 2J6, Quebec City, Quebec, Canada. Electronic address: chloe.charbonneau.1@ulaval.ca.
  • Marcoux N; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Québec (CHUQ), 11, Côte Du Palais, G1R 2J6, Quebec City, Quebec, Canada. Electronic address: nicolas.marcoux.1@ulaval.ca.
  • Blais N; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Montréal (CHUM), 1051, Rue Sanguinet, H2X 3E4, Montreal, Quebec, Canada. Electronic address: normand.blais.chum@ssss.gouv.qc.ca.
  • Leighl NB; Princess Margaret Cancer Centre, University Health Network (UNH), 610 University Ave, M5G 2C1, Toronto, Ontario, Canada. Electronic address: natasha.leighl@uhn.ca.
  • Bradbury PA; Princess Margaret Cancer Centre, University Health Network (UNH), 610 University Ave, M5G 2C1, Toronto, Ontario, Canada. Electronic address: penelope.bradbury@uhn.ca.
  • Liu G; Princess Margaret Cancer Centre, University Health Network (UNH), 610 University Ave, M5G 2C1, Toronto, Ontario, Canada. Electronic address: geoffrey.liu@uhn.ca.
  • Shepherd FA; Princess Margaret Cancer Centre, University Health Network (UNH), 610 University Ave, M5G 2C1, Toronto, Ontario, Canada. Electronic address: frances.shepherd@uhn.ca.
  • Bahig H; Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM), 900, Rue Saint-Denis, Pavillon R, H2X 0A9, Montreal, Quebec, Canada; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Montréal (CHUM), 1051, Rue Sanguinet, H2X 3E4, Montreal, Quebec, Canada. E
  • Routy B; Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM), 900, Rue Saint-Denis, Pavillon R, H2X 0A9, Montreal, Quebec, Canada; Department of Hematology and Oncology, Centre Hospitalier de L'Université de Montréal (CHUM), 1051, Rue Sanguinet, H2X 3E4, Montreal, Quebec, Canada. E
  • Sacher A; Princess Margaret Cancer Centre, University Health Network (UNH), 610 University Ave, M5G 2C1, Toronto, Ontario, Canada. Electronic address: adrian.sacher@uhn.ca.
  • Elkrief A; Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM), 900, Rue Saint-Denis, Pavillon R, H2X 0A9, Montreal, Quebec, Canada; Cedars Cancer Center, McGill University Healthcare Center (MUHC), 1001, Boulevard Décarie, H4A 3J1, Montreal, Quebec, Canada; Segal Cancer Center, Jewi
Eur J Cancer ; 142: 83-91, 2021 01.
Article em En | MEDLINE | ID: mdl-33242835
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimiorradioterapia / Antineoplásicos Imunológicos / Anticorpos Monoclonais Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimiorradioterapia / Antineoplásicos Imunológicos / Anticorpos Monoclonais Idioma: En Ano de publicação: 2021 Tipo de documento: Article